Takeda Pharmaceutical Co Ltd ADR
NYSE: TAK
$13.34
+$0.01 (+0.1%)
Real Time Data Delayed 15 Min.
TAK Stock Chart and Intraday Price
TAK Stock Data
| Asset Type | Common Stock |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | LIFE SCIENCES |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Address | 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, JP |
| Fiscal Year End | March |
| Latest Quarter | 2023-12-31 |
| Market Cap | 42,455.39M USD |
| Shares Outstanding | 3,137,830,000 |
TAK Articles
Friday's top analyst upgrades and downgrades included Adobe, Citigroup, FedEx, Foot Locker, Hewlett Packard Enterprise, Intel, Medical Properties Trust, Nike, Qualcomm, Skyworks Solutions, Takeda...
Published:
Tuesday's additional top analyst upgrades and downgrades included Apollo Global Management, Cinemark, ConocoPhillips, EOG Resources, Fastly, Southwestern Energy, Sunrun and Takeda Pharmaceutical.
Published:
One of Cathie Wood's Ark Invest funds sold nearly 850,000 shares of Takeda Pharmaceutical on December 7.
Published:
One of Cathie Wood's Ark Invest funds sold over 690,000 shares of Takeda Pharmaceutical on November 16.
Published:
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost...
Published:
These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal market...
Published:
One of Cathie Wood's Ark Invest funds sold over 350,000 shares of Takeda Pharmaceutical on June 16.
Published:
One of Cathie Wood's Ark Invest funds sold over 225,000 shares of Takeda Pharma on June 15.
Published: